Finance

Beta
Lists
WELL:TSE
WELL Health Technologies Corp
CA$4.83
-1.02%
(-0.050) 1D
Jun 3, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for WELL...
Open
CA$4.90
High
CA$5.00
Low
CA$4.80
Mkt. cap
1.23B
Avg. vol.
1.55M
Volume
2.35M
P/E ratio
46.30
52-wk high
CA$6.08
52-wk low
CA$3.58
EPS
CA$0.10
Beta
1.20
Shares outstanding
255.46M
No. of employees
3K
Open
CA$4.90
High
CA$5.00
Low
CA$4.80
Mkt. cap
1.23B
Avg. vol.
1.55M
Volume
2.35M
P/E ratio
46.30
52-wk high
CA$6.08
52-wk low
CA$3.58
EPS
CA$0.10
Beta
1.20
Shares outstanding
255.46M
No. of employees
3K
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to WELL in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for WELL in the last 3 months.
Highest
Current CA$4.83
CA$8.25 (+70.81%)
Average
CA$6.78 (+40.37%)
Lowest
CA$5.00 (+3.52%)
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
1 day ago
(WELL.DB) Stock Market Analysis (WELL.DB:CA)
Profile
WELL Health Technologies is a digital health technology company based in Canada and serving outpatient health clinics. The company owns and operates primary healthcare facilities in Canada and the United States, and provides EMR services to clinics and doctors in Canada. Well Health Technologies is publicly traded on the Toronto Stock Exchange under the symbol WELL.TO. Wikipedia
About WELL Health Technologies Corp
CEOHamed Shahbazi
Employees3.19K
Founded2018
HeadquartersVancouver, British Columbia, Canada
SectorHealth care provider
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (CAD)
- / CA$0.06
Revenue / Est. (CAD)
368.26M / 366.53M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
356.67M
364.60M
384.77M
368.26M
Cost of goods sold
197.93M
198.83M
207.91M
205.09M
Cost of revenue
197.93M
198.83M
207.91M
205.09M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102.20M
98.19M
124.51M
118.01M
Operating expense
133.41M
130.66M
155.28M
148.80M
Total operating expenses
331.34M
329.49M
363.18M
353.90M
Operating income
25.33M
35.11M
21.58M
14.36M
Other non operating income
-1.40M
-3.22M
3.48M
-926.00K
EBT including unusual items
22.92M
6.91M
18.59M
-6.78M
EBT excluding unusual items
12.40M
14.13M
6.19M
-6.49M
Income tax expense
5.92M
9.56M
-13.41M
-1.46M
Effective tax rate
25.84%
138.40%
-72.12%
21.47%
Other operating expenses
-
-
-
-
Net income
12.15M
4.17M
22.89M
-12.38M
Net profit margin
3.41%
1.14%
5.95%
-3.36%
Earnings per share
0.10
0.16
0.20
-
Interest and investment income
463.00K
342.00K
391.00K
-
Interest expense
-12.91M
-16.23M
-17.34M
-19.45M
Net interest expenses
-12.45M
-15.89M
-16.94M
-19.45M
Depreciation and amortization charges
25.40M
26.52M
22.30M
25.57M
EBITDA
50.72M
61.63M
23.22M
39.94M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more